Investigation: visual inspection: a deformation of the outer housing of the progav 2.0 valve was observed through the visual inspection.No significant deformations or damage of the shunt assistant valve was detected.Permeability test: a permeability test has indicated that the shunt assistant has a blockage and the progav 2.0 valve is permeable.Adjustment test: the progav 2.0 valve was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function is fully operational and braking force is within the given tolerances.Results: finally, we have dismantled the valves.Inside the progav 2.0 valve we found slight visible deposits (likely protein).No visible deposits were observed inside the shunt assistant valve.Based on our investigation, we confirm the presence of occlusion in the shunt assistant valve.Even a small amount of non-visible blood protein can lead to temporary blockage and could be responsible for the suspected malfunction.As described in our literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.
|